Roivant Sciences (ROIV) Stock
Roivant Sciences (ROIV) closed at $39.53 on Nov 13, 2026; its Tenet Score is 42 of 100 against 297 Healthcare peers.
26 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $39.53
- Nov 13, 2026
- Market cap
- $28.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 19.96 – 42.50
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 42/100
- Weak · 297 Healthcare peers
Industry: Drugs
Roivant Sciences Ltd scores 42/100. Weak. Strongest on financial health, growth is the soft spot versus 297 Healthcare peers.
Tenet Score · vs sector
n=297Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophospha…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| BeOne Medicines LtdONC | 64 | $47.6B |
| Biogen IncBIIB | 39 | $37.5B |
| Revolution Medicines IncRVMD | 39 | $37.3B |
| Zoetis IncZTS | 59 | $34.1B |
| Illumina IncILMN | 51 | $31.3B |
| Insmed IncINSM | 33 | $26.6B |
| United Therapeutics CorpUTHR | 72 | $25.2B |
| Incyte Corp.INCY | 60 | $24.7B |
| Alnylam Pharmaceuticals IncALNY | 51 | $22.1B |
| Medpace Holdings IncMEDP | 59 | $18.3B |
Compare Roivant Sciences with
Common questions
What sector and industry is Roivant Sciences in?
Roivant Sciences is in the Healthcare sector and the Drugs industry.
What is Roivant Sciences' Tenet Score?
Roivant Sciences' Tenet Score is 42 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.




